Status:
COMPLETED
Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
Lead Sponsor:
University of Rochester
Conditions:
Hodgkin Disease
Lymphoma, Non-Hodgkin
Eligibility:
All Genders
18+ years
Brief Summary
This study is to inquire by mailed survey regarding the cardiac and general health of patients previously treated for Hodgkin's and non-Hodgkin's lymphoma with radiation therapy/anthracycline chemothe...
Eligibility Criteria
Inclusion
- All patients with Hodgkin's Lymphoma and Non Hodgkin's lymphoma who underwent Radiation Therapy (RT) to either a mantle or modified mantle field with or without adriamycin at the Wilmot Cancer Center at the University of Rochester are eligible for the study.
Exclusion
- Any severe preexisting cardiac disease (e.g., arrhythmia, angina, coronary disease, myocardial infarction, or congestive heart failure) prior to diagnosis
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 9 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00903890
Start Date
August 1 2008
End Date
April 9 2020
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642